Patient identifier: (b)(6).All available patient information is included.Additional patient details are not available.This report is being filed on an international product, list number 06r86-23 (sars-cov-2 igg reagent kit) that has a similar product distributed in the us, list number 06r86-20 /-30 (sars-cov-2 igg assay), eua (b)(4).An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
|
The customer was conducting a health screening for staff members.Out of the 415 patient samples tested, the customer observed false positive architect sars-cov-2 igg results for 9 samples while running on the architect i2000sr analyzer.The following results were provided (reference range: < 1.4 index is negative, >/= 1.4 index is positive): sid (b)(6): initial result: 1.71 index, repeat results: 0.05, 0.05 index.Sid (b)(6) : initial result: 2.48 index, repeat results: 0.03, 0.03 index.Sid (b)(6): initial result: 1.96 index, repeat results: 0.04, 0.04 index.Sid (b)(6): initial result: 1.58 index, repeat results: 0.77, 0.78 index.Sid (b)(6): initial result: 1.79 index, repeat results: 0.04, 0.03 index.Sid (b)(6): initial result: 1.73 index, repeat results: 0.06, 0.07 index.Sid (b)(6): initial result: 1.62 index, repeat results: 0.05, 0.05 index.Sid (b)(6): initial result: 1.57 index, repeat results: 0.03, 0.03 index.Sid (b)(6): initial result: 1.47 index, repeat results: 0.05, 0.05 index.There was no impact to patient management reported.
|
The complaint investigation for false positive architect sars-cov-2 igg results included a search for similar complaints, and the review of complaint text, trending data, labeling, and device history records.Return testing was not performed as returns were not available.A ticket search by lot indicates that the reagent lot performs as expected for this product.Tracking and trending determined no related trends for the product and for the complaint issue.Clinical specificity and sensitivity testing was performed using an in-house retain kit of lot 33209fn00.All specifications were met indicating the lot is performing acceptably.The device history records were reviewed and did not identify any non-conformances, potential non-conformances, or deviations related to the likely cause lot number or related to the complaint.Labeling was reviewed and adequately addresses the issue under review.Based on the investigation, no systemic issue or product deficiency for architect sars-cov-2 igg reagent lot 33209fn00 was identified.
|